Review on Artificial Intelligence in Pharmacovigilance: Opportunities and Challenges

Due to the clever gathering and reporting of individual case safety reports, as well as the increased awareness and involvement of patients and healthcare professionals, the number of suspected adverse event reports in the PV database has grown exponentially. The PV case processing cycle starts with data collection, data entry, initial checking completeness and validity, coding, medical assessment for causality expectedness, severity, and seriousness, subsequently submitting report, quality checking followed by data storage and maintenance. Artificial intelligence (AI) in health care has been very impressive in specialties that rely heavily on the interpretation of medical images. The focus should be a collaborative approach of technical expertise (people) combined with intelligent technology (processes) to augment human talent that meets the objective of the PV system and benefit all stakeholders. AI technology should enhance human intelligence rather than substitute human experts. This review describes the benefits and the outstanding scientific, technological, and policy issues, and the maturity of AI tools for full automation in the context to the Indian health-care system

Authors

Publication Details

Journal
International Journal of Advanced Research in Science Communication and Technology
Published
2024-11-27
DOI
https://doi.org/10.48175/ijarsct-22464
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Review on Artificial Intelligence in Pharmacovigilance: Opportunities and Challenges

D. Ramesh, Fulsundar Apeksha
International Journal of Advanced Research in Science Communication and Technology
Pharmacovigilance and Adverse Drug Reactions
article

Review on Artificial Intelligence in Pharmacovigilance: Opportunities and Challenges

D. Ramesh, Fulsundar Apeksha
article en

Abstract

Due to the clever gathering and reporting of individual case safety reports, as well as the increased awareness and involvement of patients and healthcare professionals, the number of suspected adverse event reports in the PV database has grown exponentially. The PV case processing cycle starts with data collection, data entry, initial checking completeness and validity, coding, medical assessment for causality expectedness, severity, and seriousness, subsequently submitting report, quality checking followed by data storage and maintenance. Artificial intelligence (AI) in health care has been very impressive in specialties that rely heavily on the interpretation of medical images. The focus should be a collaborative approach of technical expertise (people) combined with intelligent technology (processes) to augment human talent that meets the objective of the PV system and benefit all stakeholders. AI technology should enhance human intelligence rather than substitute human experts. This review describes the benefits and the outstanding scientific, technological, and policy issues, and the maturity of AI tools for full automation in the context to the Indian health-care system

International Journal of Advanced Research in Science Communication and Technology
Partnerships for the goals
Openalex Percentile: Top 79%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Review on Artificial Intelligence in Pharmacovigilance: Opportunities and Challenges — D. Ramesh, Fulsundar Apeksha · International Journal of Advanced Research in Science Communication and Technology (2024) | TGRS Research Map | TGRS